Article
Multisite Investigation of Strategies for the Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy.
Clinical pharmacology and therapeutics - 1 Oct 2018
Empey Philip E, Stevenson James M, Tuteja Sony, Weitzel Kristin W, Angiolillo Dominick J, Beitelshees Amber L, Coons James C, Duarte Julio D, Franchi Francesco, Jeng Linda J B, Johnson Julie A, Kreutz Rolf P, Limdi Nita A, Maloney Kristin A, Owusu Obeng Aniwaa, Peterson Josh F, Petry Natasha, Pratt Victoria M, Rollini Fabiana, Scott Stuart A, Skaar Todd C, Vesely Mark R, Stouffer George A, Wilke Russell A, Cavallari Larisa H, Lee Craig R
Abstract excerpt
CYP2C19 genotype-guided antiplatelet therapy following percutaneous coronary intervention is increasingly implemented in clinical practice. However, challenges such as selecting a testing platform, communicating test results, building clinical decision support processes, providing patient and provider education, and integrating methods to support the translation of emerging evidence to clinical practice are...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
